ClinConnect ClinConnect Logo
Search / Trial NCT06872086

Assessment of Blood Indices in Systemic Lupus Erythematosus

Launched by ASSIUT UNIVERSITY · Mar 7, 2025

Trial Information

Current as of April 22, 2025

Not yet recruiting

Keywords

Sle Systemic Lupus Erythematosus Blood Indices

ClinConnect Summary

This case-control study will be conducted at Assiut University Hospital, involving 70 patients diagnosed with SLE according to the 2019 ACR/EULAR classification criteria and 70 healthy controls matched for age and gender. Inclusion criteria include patients aged 18 years or older with SLE, while exclusion criteria include other autoimmune diseases, recent infections, and hematological disorders unrelated to SLE.

Study Tools and Procedures:

Demographic Information: Collect data on age, gender, duration of illness, and relevant medical history.

Clinical Assessment: Disease activity will be...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 18 years or older diagnosed with SLE according to the 2019 ACR/EULAR classification criteria.
  • Healthy controls without any autoimmune diseases or significant comorbidities
  • Exclusion Criteria:
  • • Patients with other autoimmune diseases (e.g., rheumatoid arthritis, Sjögren's syndrome).
  • Recent infections or acute inflammatory conditions.
  • Individuals with hematological disorders unrelated to SLE (e.g., leukemia, lymphoma).

About Assiut University

Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported